1. Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes. Issue 1 (13th February 2019) Authors: Kotwal, Anupam; Haddox, Candace; Block, Matthew; Kudva, Yogish C Journal: BMJ open diabetes research and care Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study. (4th December 2022) Authors: Gien, Lilian; Enserro, Danielle; Block, Matthew; Waggoner, Steven; Duska, Linda; Hendrickson, Andrea Wahner; Thaker, Premal; Backes, Floor; Bottsford-Miller, Justin; Muller, Carolyn; Disilvestro, Paul; Covens, Allan; Gershenson, David; Moore, Kathleen; Aghajanian, Carol; Coleman, Robert L Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma. Issue 2 (30th January 2019) Authors: Kumar, Anagha Bangalore; Aguilera, Jesus Vera; Velazquez, Ana; Yan, Yiyi; Jakub, James; Brewer, Jerry; Hieken, Tina; Block, Matthew; McWilliams, Robert; Otley, Clark; Markovic, Svetomir; Kottschade, Lisa Journal: Dermatologic therapy Issue: Volume 32:Issue 2(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗